Jpmorgan Chase & CO Rockwell Medical, Inc. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 35 shares of RMTI stock, worth $41. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35
Previous 3,463
98.99%
Holding current value
$41
Previous $7,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding RMTI
# of Institutions
49Shares Held
5.93MCall Options Held
129KPut Options Held
10.4K-
Armistice Capital, LLC New York, NY2.15MShares$2.54 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.21MShares$1.42 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny542KShares$639,2660.0% of portfolio
-
Geode Capital Management, LLC Boston, MA321KShares$378,3840.0% of portfolio
-
Globeflex Capital L P San Diego, CA312KShares$368,2240.02% of portfolio
About ROCKWELL MEDICAL, INC.
- Ticker RMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 10,675,200
- Market Cap $12.6M
- Description
- Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...